AzTrials
AzTrials

Attention Deficit and Disruptive Behavior DisordersOASISNCT05683756

Optimizing Attention and Sleep Intervention Study

A study testing Brief Parent Behavioral Intervention and Sleep-Focused Parent Behavioral Intervention in people with Attention Deficit and Disruptive Behavior Disorders and Attention Deficit Hyperactivity Disorder, run by University of Pittsburgh at 7 sites in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goal of this pilot clinical effectiveness trial is to compare a brief parent behavioral intervention (PBI) to a modified sleep focused PBI (SF-PBI) delivered by therapists in pediatric primary care for families of children 3-5 years old with sleep problems and early ADHD symptoms. Read more about this study

Who is it for?
Ages 3 to 5 years
What is being tested?
Brief Parent Behavioral Intervention and Sleep-Focused Parent Behavioral Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
7 sitesUnited States
Study dates
1 Dec 2023to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 5 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Parent/Caregiver:
  • (1) Legal guardian is at least 18 years of age
  • (2) Reads and speaks English
  • Child:
  • (1) 3-5 years of age
  • (2) Caregiver report of 4 or more ADHD symptoms
Show all 9Show fewer
  • (3) Caregiver reports child's sleep as a "moderate" or "serious problem"
  • (4) English speaking
  • (5) Child receives care from participating pediatric primary care office

Who cannot join

  • (1) Sleep interfering medical diagnoses (e.g., narcolepsy, obstructive sleep apnea)
  • (2) Severe neurodevelopmental disorder

Trial locations and contacts

7 sites in 1 country.

7 sites in 1 country

United States7 sites
  • Children's Community Pediatrics Bass Wolfson, Cranberry

    Cranberry Township, Pennsylvania, 16066

  • Children's Community Pediatrics GIL Murrysville

    Monroeville, Pennsylvania, 15146

  • Children's Community Pediatrics Shenango

    New Castle, Pennsylvania, 16101

  • Children's Community Pediatrics Neshannock

    New Castle, Pennsylvania, 16105

  • Children's Community Pediatrics GIL East Liberty

    Pittsburgh, Pennsylvania, 15206

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15213

  • Children's Community Pediatrics Bass Wolfson, Squirrel Hill

    Pittsburgh, Pennsylvania, 15217

Other trials in United States

About this study

Official title: Optimizing Attention and Sleep Intervention Study: A Pilot RCT to Compare Parent Behavioral Interventions With and Without Sleep Strategies Delivered in Pediatric Primary Care for Preschool-aged Children at Risk of Childhood ADHD

The goal of this pilot clinical effectiveness trial is to compare a brief parent behavioral intervention (PBI) to a modified sleep focused PBI (SF-PBI) delivered by therapists in pediatric primary care for families of children 3-5 years old with sleep problems and early ADHD symptoms.

The main aims are to:

Aim 1: Demonstrate the acceptability, feasibility, and appropriateness of the sleep focused PBI (SF-PBI) delivered in pediatric primary care for preschool-aged children (3-5 years old) at elevated risk for ADHD.

Aim 2: Examine change in target engagement (sleep) and ADHD symptoms among preschool-aged children at elevated risk for ADHD receiving SF-PBI compared to standard PBI.

Read the detailed description

Sleep problems may be one mechanism through which young children may be at risk for developing ADHD, although first line ADHD interventions, including parent behavioral interventions (PBIs), do not address sleep. Investigators will test a modified version of a PBI to target sleep disrupting behaviors for children 3-5 years old at elevated risk for ADHD. The intervention will be delivered by behavioral health therapists embedded in pediatric primary care to increase families' access to intervention. This pilot effectiveness trial is the first step towards developing an early intervention targeting sleep as a mechanism to reduce the prevalence, symptoms, and impairments associated with childhood ADHD.

Being tested
Brief Parent Behavioral Intervention, Sleep-Focused Parent Behavioral Intervention
Medical subject headings
Attention Deficit and Disruptive Behavior Disorders, Attention Deficit Disorder with Hyperactivity, Parasomnias

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brief Parent Behavioral InterventionBehavioural

    PBI administered in pediatric primary care by an embedded therapist.

  • Sleep-Focused Parent Behavioral InterventionBehavioural

    SF-PBI administered in pediatric primary care by an embedded therapist.

Study groups in NCT05683756
Study groupRoleWhat they receive
Brief Parent Behavioral InterventionActive comparatorA brief parent behavioral intervention with evidenced based strategies for treatment of ADHD.
Receives: Behavioral: Brief Parent Behavioral Intervention
Sleep-Focused Parent Behavioral InterventionExperimentalA modified version of the brief parent behavioral intervention that specifically targets sleep disrupting behaviors.
Receives: Behavioral: Sleep-Focused Parent Behavioral Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intervention Acceptability

    Therapists and caregiver report of intervention acceptability will be assessed using the 4-item Acceptability of Intervention Measure (AIM), rated from 1-completely disagree to 5-completely agree, with scores greater than or equal to 16 indicating good acceptability.

    Measured: Post Intervention at approximately 4 months

  2. Intervention Appropriateness

    Therapists and caregiver report of intervention appropriateness will be assessed using the 4-item Intervention Appropriateness Measure (IAM), rated from 1-completely disagree to 5-completely agree, with scores greater than or equal to 16 indicating good appropriateness.

    Measured: Post Intervention at approximately 4 months

  3. Intervention Feasibility

    Therapists and caregiver report of intervention feasibility will be assessed using the 4-item Feasibility of Intervention Measure (FIM), rated from 1-completely disagree to 5-completely agree, with scores greater than or equal to 16 indicating good feasibility.

    Measured: Post Intervention at approximately 4 months

  4. Problematic Sleep

    Using the Brief Child Sleep Questionnaire caregivers will report on their perception of child's sleep as problematic, rated 1 (Not at all) to 5 (A serious problem).

    Measured: Change from baseline up to 8 months

  5. ADHD Symptoms

    Using the 18-item ADHD Rating Scale-IV-Preschool Version caregivers will report on the child's ADHD symptoms. Symptoms are rated from 0 (Rarely) to 3 (Very Often).

    Measured: Change from baseline up to 8 months

Secondary outcomes (3)
  1. Nighttime Awakenings

    Caregivers will report how many times their child typically wakes during the night, using the Brief Child Sleep Questionnaire.

    Measured: Change from baseline up to 8 months

  2. Sleep Latency

    Sleep latency will be determined by using the caregiver report of how long it typically takes their child to fall asleep (number of minutes), using the Brief Child Sleep Questionnaire.

    Measured: Change from baseline up to 8 months

  3. Consistency of Bedtime Routine

    Caregivers will report the number of days, in a typical week, they regularly put their child to bed at the same time (within 15 minutes), using the Brief Child Sleep Questionnaire.

    Measured: Change from baseline up to 8 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2023
  2. Study start1 Dec 2023
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05683756
Sponsor's protocol ID
STUDY22070096
Other IDs
R34MH131993
Acronym
OASIS
Status last verified
Jun 2026
First submitted
24 Nov 2022
Last updated
9 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual participant data collected during the trial will be shared, after deidentification, via the NIMH National Data Archive.

Publications

  • Cunningham CE, Bremner R, Boyle M. Large group community-based parenting programs for families of preschoolers at risk for disruptive behaviour disorders: utilization, cost effectiveness, and outcome. J Child Psychol Psychiatry. 1995 Oct;36(7):1141-59. doi: 10.1111/j.1469-7610.1995.tb01362.x.

    PubMed 8847377
  • Joseph HM, Levenson JC, Conlon RPK, Mannion K, Kipp HL, Gradian A, Wallace ML, Williamson AA. Optimizing Attention and Sleep Intervention Study (OASIS): a protocol for a pilot randomized controlled trial to compare parent behavioral interventions with and without sleep strategies delivered in pediatric primary care for preschool-aged children at risk of childhood ADHD. Pilot Feasibility Stud. 2025 Feb 25;11(1):22. doi: 10.1186/s40814-025-01600-0.

    PubMed 40001155

Questions about this trial

What is this clinical trial studying?

A study testing Brief Parent Behavioral Intervention and Sleep-Focused Parent Behavioral Intervention in people with Attention Deficit and Disruptive Behavior Disorders and Attention Deficit Hyperactivity Disorder, run by University of Pittsburgh at 7 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 9 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intervention Acceptability (time frame: Post Intervention at approximately 4 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05683756, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in